Bacteriological aetiology and antimicrobial treatment of pleural empyema
- 25 November 2010
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 43 (3) , 165-169
Abstract
Background: Our aims were to describe the aetiologies of culture-positive pleural infections and to evaluate the choice of empiric antimicrobial treatment regimens according to antimicrobial sensitivity, and to evaluate the possible influence of this on outcome. Methods: All cases over a 9-y period were identified from 3 hospitals using the laboratory databases of the clinical microbiology departments, and were verified by evaluating the medical records. Results: We identified 291 isolates in pleural fluid cultures from 158 patients. These included viridans streptococci (25%), Staphylococcus aureus (18%), anaerobic bacteria (17%), Enterobacteriaceae (12%), Staphylococcus epidermidis (10%), and Streptococcus pneumoniae (7%), with differences between nosocomial and community-acquired infections. The mortality (overall 27%) was highest among the patients with Enterobacteriaceae (50%) and S. aureus (36%) infections, and in patients with mixed infections (34%). The actual empiric treatment or the recommended penicillin plus metronidazole had low antimicrobial coverage (49%) compared to the proposed cefuroxime plus metronidazole (78%). Thoracentesis was often delayed (median 2 days). The adequacy of empiric antimicrobial therapy was independently correlated with mortality (odds ratio 0.43, 95% confidence interval 0.30–0.62). Conclusions: The early diagnosis of pleural infection could be optimized. In this North-European patient population, we suggest that the recommended empiric antimicrobial treatment be changed to cefuroxime plus metronidazole for community-acquired and nosocomial infections.Keywords
This publication has 14 references indexed in Scilit:
- Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemicJournal of Antimicrobial Chemotherapy, 2010
- Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumoniaThorax, 2009
- The Bacteriology of Pleural Infection by Genetic and Standard Methods and Its Mortality SignificanceAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Thoracic Empyema in Patients with Community-Acquired PneumoniaThe American Journal of Medicine, 2006
- U.K. Controlled Trial of Intrapleural Streptokinase for Pleural InfectionNew England Journal of Medicine, 2005
- INFECTION OF THE PLEURAL SPACEClinics in Chest Medicine, 1999
- The clinical course and management of thoracic empyemaQJM: An International Journal of Medicine, 1996
- Treatment of pleural empyema secondary to pneumonia: thoracocentesis regimen versus tube drainage.Thorax, 1992
- CDC definitions for nosocomial infections, 1988American Journal of Infection Control, 1988
- Changing Ecology of Acute Bacterial Empyema: Occurrence and Mortality at Boston City Hospital during 12 Selected Years from 1935 to 1972The Journal of Infectious Diseases, 1978